from Marguerite Arnold
Germany is the top target market for cannabis companies globally, but where your cultivator or distributor is located, especially in the realm of API standards, can make all the difference.
Destination Germany is the watchword for those in the international cannabis industry—but it is still a rocky path to gaining access for most. Specifically, there is a lot of confusion surrounding API and cannabis classification and issues from a lack of consistent standards.
One of the most intriguing aspects of the process currently is how flower is categorized (especially for imports) once it gets to the country. For a country of rules, this is surprisingly all over the place right now. There is no one single answer—which rules apply depend on both the regulatory requirement at point of cultivation as well as distribution (on a state, not federal, level).
This can also be frustrating even within Germany and the EU—namely because of a lack of homogeneity still, that exists in the treatment of cannabis flower—both within the region and at a sovereign level. This is especially true where pharmaceutical guidelines cross those for irradiating anything bound for consumption by consumers.